<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="19/03/2006" creator="Junko Matsuura" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8101106">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8101106</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Polynucleotide" id="A1"><term sem="Polynucleotide" id="T1" lex="antisense_oligonucleotide">Antisense oligonucleotides</term> to the <term sem="Protein_molecule" id="T2" lex="p65_subunit">p65 subunit</term></term> of <term sem="Protein_molecule" id="T3" lex="NF-kappa_B">NF-kappa B</term> block <term sem="Other" id="T4" lex="CD11b_expression"><term sem="Protein_molecule" id="T5" lex="CD11b">CD11b</term> expression</term> and alter <term sem="Other" id="T6" lex="adhesion_property">adhesion properties</term> of differentiated <term sem="Cell_cultured" id="T7" lex="HL-60_granulocyte">HL-60 granulocytes</term>.</sentence>
<event id="E1">
<type class="Gene_expression" />
<theme idref="T5" />
<clue>Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b <clueType>expression</clueType> and alter adhesion properties of differentiated HL-60 granulocytes.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Antisense oligonucleotides to the p65 subunit of NF-kappa B <clueType>block</clueType> CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.</clue>
</event>
<event id="E3">
<type class="Regulation" />
<theme idref="T7" />
<cause idref="A1" />
<clue>Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and <clueType>alter adhesion properties</clueType> <linkTheme>of</linkTheme> differentiated HL-60 granulocytes.</clue>
<comment>TPS: A1</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="T8" lex="NF-kappa_B">NF-kappa B</term> is a <term sem="Protein_family_or_group" id="T9" lex="pleiotropic_regulator">pleiotropic regulator</term> of a <term sem="DNA_domain_or_region" id="A30"><term sem="DNA_domain_or_region" id="A2">variety of genes</term> implicated in the <term sem="Other" id="A4">cellular response to injury</term>.</term></sentence>
<event id="E4">
<type class="Regulation" />
<theme idref="A30" />
<cause idref="T8" />
<clue>NF-kappa B is a pleiotropic <clueType>regulator</clueType> <linkTheme>of</linkTheme> a variety of genes implicated in the cellular response to injury.</clue>
<comment>TPS:A2, A4, A30</comment>
</event>
<event id="E21">
<type class="Correlation" />
<theme idref="A2" />
<theme idref="A4" />
<clue>NF-kappa B is a pleiotropic regulator of a variety of genes <clueType>implicated</clueType> <linkTheme>in</linkTheme> the cellular response to injury.</clue>
<comment>TPS: A4</comment>
</event>
<sentence id="S3">This function has been attributed to the coordinated binding of subunits of <term sem="Protein_molecule" id="T10" lex="NF-kappa_B">NF-kappa B</term> to distinct regions of the <term sem="DNA_family_or_group" id="T11" lex="promoter_element">promoter elements</term> of numerous genes, including <term sem="Protein_family_or_group" id="T12" lex="cytokine">cytokines</term>, <term sem="Protein_family_or_group" id="T13" lex="growth_factor_receptor">growth factor receptors</term>, and <term sem="Protein_family_or_group" id="T14" lex="adhesion_molecule">adhesion molecules</term>.</sentence>
<event id="E22">
<type class="Binding" />
<theme idref="T10" />
<theme idref="T12" />
<clue>This function has been attributed to the coordinated <clueType>binding</clueType> <linkTheme>of</linkTheme> subunits of NF-kappa B <linkTheme>to</linkTheme> distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.</clue>
</event>
<event id="E23">
<type class="Binding" />
<theme idref="T10" />
<theme idref="T13" />
<clue>This function has been attributed to the coordinated <clueType>binding</clueType> <linkTheme>of</linkTheme> subunits of NF-kappa B <linkTheme>to</linkTheme> distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="T10" />
<theme idref="T14" />
<clue>This function has been attributed to the coordinated <clueType>binding</clueType> <linkTheme>of</linkTheme> subunits of NF-kappa B <linkTheme>to</linkTheme> distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="E22" />
<clue><corefTheme>This function</corefTheme> has been <clueType>attributed</clueType> <linkCause>to</linkCause> the coordinated binding of subunits of NF-kappa B to distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="E23" />
<clue><corefTheme>This function</corefTheme> has been <clueType>attributed</clueType> <linkCause>to</linkCause> the coordinated binding of subunits of NF-kappa B to distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.</clue>
</event>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="E24" />
<clue><corefTheme>This function</corefTheme> has been <clueType>attributed</clueType> <linkCause>to</linkCause> the coordinated binding of subunits of NF-kappa B to distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules.</clue>
</event>
<sentence id="S4"><term sem="Polynucleotide" id="T15" lex="antisense_phosphorothioate_oligonucleotide">Antisense phosphorothioate oligonucleotides</term> to the <term sem="Protein_molecule" id="T16" lex="p50">p50</term> and <term sem="Protein_molecule" id="T17" lex="p65_subunit">p65 subunits</term> of the <term sem="Protein_complex" id="T18" lex="NF-kappa_B_complex">NF-kappa B complex</term> were used to define the physiologic role of this <term sem="Protein_family_or_group" id="T19" lex="transcription_factor">transcription factor</term> in <cons sem="(AND Cell_cultured Cell_cultured)" id="T20" lex="(AND resting_granulocyte stimulated_granulocyte)"><frag id="F1">resting</frag> and <frag id="F2">stimulated</frag> <frag id="F3"><term sem="Cell_natural" id="A21">granulocytes</term></frag></cons>.</sentence>
<event uncertainty="doubtful" id="E300">
<type class="Regulation" />
<cause idref="T18" />
<clue><clueExperiment>Antisense phosphorothioate oligonucleotides to the p50 and p65 subunits of the NF-kappa B complex were used</clueExperiment> to define the <clueType>physiologic role</clueType> <linkCause>of</linkCause> <corefTheme>this transcription factor</corefTheme> <clueLoc>in resting</clueLoc> and stimulated <clueLoc>granulocytes</clueLoc>.</clue>
</event>
<event uncertainty="doubtful" id="E301">
<type class="Regulation" />
<cause idref="T18" />
<clue><clueExperiment>Antisense phosphorothioate oligonucleotides to the p50 and p65 subunits of the NF-kappa B complex were used</clueExperiment> to define the <clueType>physiologic role</clueType> <linkCause>of</linkCause> <corefTheme>this transcription factor</corefTheme> <clueLoc>in</clueLoc> resting and <clueLoc>stimulated granulocytes</clueLoc>.</clue>
</event>
<event id="E35">
<type class="Physiological_process" />
<theme idref="A21" />
<clue>Antisense phosphorothioate oligonucleotides to the p50 and p65 subunits of the NF-kappa B complex were used to define the physiologic role of this transcription factor in resting and <clueType>stimulated</clueType> granulocytes.</clue>
</event>
<sentence id="S5">A reduction in the expression of <term sem="Protein_molecule" id="T21" lex="p65">p65</term> was produced by treatment with the <term sem="Polynucleotide" id="T22" lex="phosphorothioate_antisense_oligodeoxynucleotide">phosphorothioate antisense oligodeoxynucleotide</term>.</sentence>
<event id="E6">
<type class="Gene_expression" />
<theme idref="T21" />
<clue>A reduction in the <clueType>expression</clueType> <linkTheme>of</linkTheme> p65 was produced by treatment with the phosphorothioate antisense oligodeoxynucleotide.</clue>
</event>
<event id="E36">
<type class="Artificial_process" />
<theme idref="T22" />
<clue>A reduction in the expression of p65 was produced by <clueType>treatment</clueType> <linkTheme>with</linkTheme> the phosphorothioate antisense oligodeoxynucleotide.</clue>
</event>
<event id="E7">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="E36" />
<clue>A <clueType>reduction</clueType> <linkTheme>in</linkTheme> the expression of p65 was produced <linkCause>by</linkCause> treatment with the phosphorothioate antisense oligodeoxynucleotide.</clue>
</event>
<sentence id="S6">This reduction was accompanied by rapid changes in the <term sem="Other" id="A3">cellular adhesion</term> of <term sem="Cell_cultured" id="T23" lex="dimethyl_sulfoxide-differentiated_HL-60_leukemia_cell"><term sem="Organic_compound_other" id="T24" lex="dimethyl_sulfoxide">dimethyl sulfoxide</term>-differentiated <term sem="Cell_cultured" id="A7">HL-60 leukemia cells</term></term> stimulated by <term sem="Organic_compound_other" id="T25" lex="12-O-tetradecanoylphorbol_13-acetate">12-O-tetradecanoylphorbol 13-acetate</term> (<term sem="Organic_compound_other" id="T26" lex="TPA">TPA</term>).</sentence>
<event id="E8">
<type class="Regulation" />
<theme idref="A3" />
<cause idref="E7" />
<clue><corefCause>This reduction</corefCause> was accompanied by rapid <clueType>changes</clueType> <linkTheme>in</linkTheme> the cellular adhesion of <clueLoc>dimethyl sulfoxide-differentiated HL-60 leukemia cells stimulated by 12-O-tetradecanoylphorbol 13-acetate (TPA).</clueLoc></clue>
</event>
<event id="E25">
<type class="Physiological_process" />
<theme idref="T23" />
<cause idref="T26" />
<clue>This reduction was accompanied by rapid changes in the cellular adhesion of dimethyl sulfoxide-differentiated HL-60 leukemia cells <clueType>stimulated</clueType> <linkCause>by</linkCause> 12-O-tetradecanoylphorbol 13-acetate (TPA).</clue>
</event>
<event id="E126">
<type class="Cell_differentiation" />
<theme idref="A7" />
<clue>This reduction was accompanied by rapid changes in the cellular adhesion of dimethyl sulfoxide-<clueType>differentiated</clueType> HL-60 leukemia cells stimulated by 12-O-tetradecanoylphorbol 13-acetate (TPA).</clue>
</event>
<event id="E127">
<type class="Positive_regulation" />
<theme idref="E126" />
<cause idref="T24" />
<clue>This reduction was accompanied by rapid changes in the cellular adhesion of dimethyl sulfoxide-<clueType>differentiated</clueType> HL-60 leukemia cells stimulated by 12-O-tetradecanoylphorbol 13-acetate (TPA).</clue>
</event>
<sentence id="S7">These effects were characterized by a marked reduction in <term sem="Other" id="T27" lex="CD11b_integrin_expression"><term sem="Protein_molecule" id="T28" lex="CD11b">CD11b</term> <term sem="Protein_family_or_group" id="T29" lex="integrin">integrin</term> expression</term> on the surface of <term sem="Cell_cultured" id="T30" lex="treated_cell">treated cells</term>.</sentence>
<event id="E9">
<type class="Gene_expression" />
<theme idref="T28" />
<clue>These effects were characterized by a marked reduction in CD11b integrin <clueType>expression</clueType> <clueLoc>on the surface of treated cells.</clueLoc></clue>
</event>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="E9" />
<cause idref="E36" />
<clue>These effects were characterized by a marked <clueType>reduction</clueType> <linkTheme>in</linkTheme> CD11b integrin expression on the surface of treated cells.</clue>
</event>
<event id="E11">
<type class="Correlation" />
<theme idref="E10" />
<theme idref="E8" />
<clue><corefTheme idref1="E8">These effects</corefTheme> were <clueType>characterized</clueType> <linkTheme>by</linkTheme> a marked reduction in CD11b integrin expression on the surface of treated cells.</clue>
</event>
<sentence id="S8">Furthermore, the <term sem="Polynucleotide" id="T31" lex="p65_antisense_oligomerp"><term sem="Protein_molecule" id="T32" lex="p65">p65</term> antisense oligomer</term> effectively abolished an upregulation of <term sem="Protein_molecule" id="T33" lex="CD11b">CD11b</term> that was produced by <term sem="Peptide" id="T34" lex="formyl-met-leu-phe">formyl-met-leu-phe</term> and <term sem="Organic_compound_other" id="T35" lex="TPA">TPA</term>.</sentence>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref="T34" />
<clue>Furthermore, the p65 antisense oligomer effectively abolished an <clueType>upregulation</clueType> <linkTheme>of</linkTheme> CD11b that was produced <linkCause>by</linkCause> formyl-met-leu-phe and TPA.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref="T35" />
<clue>Furthermore, the p65 antisense oligomer effectively abolished an <clueType>upregulation</clueType> <linkTheme>of</linkTheme> CD11b that was produced <linkCause>by</linkCause> formyl-met-leu-phe and TPA.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="T31" />
<clue>Furthermore, the p65 antisense oligomer effectively <clueType>abolished</clueType> an upregulation of CD11b that was produced by formyl-met-leu-phe and TPA.</clue>
</event>
<event id="E15">
<type class="Negative_regulation" />
<theme idref="E13" />
<cause idref="T31" />
<clue>Furthermore, the p65 antisense oligomer effectively <clueType>abolished</clueType> an upregulation of CD11b that was produced by formyl-met-leu-phe and TPA.</clue>
</event>
<sentence id="S9">However, the <term sem="Polynucleotide" id="T36" lex="p65_antisense_phosphorothioate_oligodeoxynucleotide"><term sem="Protein_molecule" id="T37" lex="p65">p65</term> antisense phosphorothioate oligodeoxynucleotide</term> had no significant effect on the production of <term sem="Inorganic_compound" id="T38" lex="reactive_oxygen_intermediate">reactive oxygen intermediates</term> or on <term sem="Other" id="T39" lex="phagocytosis">phagocytosis</term> by these cells.</sentence>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T38" />
<clue>However, the p65 antisense phosphorothioate oligodeoxynucleotide had no significant effect on the <clueType>production</clueType> <linkTheme>of</linkTheme> reactive oxygen intermediates or on phagocytosis by these cells.</clue>
</event>
<event assertion="non-exist" id="E17">
<type class="Regulation" />
<theme idref="E16" />
<cause idref="T36" />
<clue>However, the p65 antisense phosphorothioate oligodeoxynucleotide had no significant <clueType>effect</clueType> <linkTheme>on</linkTheme> the production of reactive oxygen intermediates or on phagocytosis by these cells.</clue>
</event>
<event assertion="non-exist" id="E18">
<type class="Regulation" />
<theme idref="T39" />
<cause idref="T36" />
<clue>However, the p65 antisense phosphorothioate oligodeoxynucleotide had no significant <clueType>effect</clueType> <linkTheme>on</linkTheme> the production of reactive oxygen intermediates or on phagocytosis by these cells.</clue>
</event>
<sentence id="S10">These findings indicate that <term sem="Polynucleotide" id="T40" lex="antisense_oligomer">antisense oligomers</term> to <term sem="Protein_molecule" id="T41" lex="p65">p65</term> can be used to define the role of <term sem="Protein_molecule" id="T42" lex="NF-kappa_B">NF-kappa B</term> in the <term sem="Other" id="T43" lex="activation_pathway">activation pathways</term> of <term sem="Cell_natural" id="T44" lex="neutrophil">neutrophils</term>.</sentence>
<event id="E19">
<type class="Physiological_process" />
<theme idref="T44" />
<clue>These findings indicate that antisense oligomers to p65 can be used to define the role of NF-kappa B in the <clueType>activation</clueType> pathways <linkTheme>of</linkTheme> neutrophils.</clue>
</event>
<event uncertainty="doubtful" id="E20">
<type class="Regulation" />
<theme idref="T42" />
<cause idref="T42" />
<clue>These findings indicate that <clueExperiment>antisense oligomers to p65</clueExperiment> can be used to define the <clueType>role</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkTheme>in</linkTheme> the activation pathways of neutrophils.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
